In our study, people with T1D displayed a significantly lower frequency of CD4+ T cells after the full vaccination protocol and after the booster dose, and this was accompanied by a significant reduction in the percentage of people with T1D with S‐specific CD4+ T cell responses compared with ND. This evidence concerns the gene CD4 and type 1 diabetes mellitus.